All these reports point out the need to further investigate more deeply the molecular mechanism by which Hakai mediates its action on tumor progression, not only by its influence on EMT though E-cadherin downregulation but also by its influence on early stages of tumor formation. The gene discussed is CBLL1; the disease is neoplasm.